New Eng J Med Vol 350
991 At last some good news for those taking hormone replacement therapy: it protects against bowel cancer.
1005 The best way to measure risk in patients with chronic obstructive airways disease (COPD) is to combine measurement of the FEV1 with body mass index, 6–minute walking distance and a dyspnoea scale (together they form the BODE index).
1081 Another trial showing the superiority of aromatase inhibitors over tamoxifen in breast cancer — this time exemestane directly after primary treatment.
1104 The mysterious pathways of migraine involve calcitonin-gene related peptide, which can now be blocked with good effect.
1189 Alendronate is safe, well-tolerated and highly effective in preventing osteoporosis in post-menopausal treatment — nice treatment if NICE people will let you have it.
Lancet Vol 363
757 The Heart Protection Study used simvastatin at 40 mg in patients with vascular risk and demonstrated a reduction in …